Standout Papers

Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-posit... 2012 2026 2016 2021 505
  1. Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study (2012)
    Thomas Bachelot, Gilles Romieu et al. The Lancet Oncology

Immediate Impact

2 by Nobel laureates 3 from Science/Nature 55 standout
Sub-graph 1 of 21

Citing Papers

Invasion and metastasis in cancer: molecular insights and therapeutic targets
2025 Standout
Functionalized Nanomaterials Capable of Crossing the Blood–Brain Barrier
2024 Standout
1 intermediate paper

Works of C. Labbé-Devilliers being referenced

Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study
2012 Standout

Author Peers

Author Last Decade Papers Cites
C. Labbé-Devilliers 25 38 481 458 158 11 586
Noah Goodman 6 38 371 269 83 12 628
Shu-Fang Hsu Schmitz 14 165 285 339 82 9 568
Chanchal Goswami 4 59 383 288 71 20 544
Yenting Ngai 8 29 268 376 40 17 544
Sachiko Kawana 23 61 492 242 47 17 576
Olga Torres 5 31 359 220 99 12 572
Irene De Santo 14 68 381 328 72 13 665
J.-L. Lagrange 6 72 362 224 128 15 578
Jun Sugisaka 4 40 587 281 50 20 662
Catherine Chodkiewicz 5 27 385 267 163 10 636

All Works

Loading papers...

Rankless by CCL
2026